Columbia University

Technology Ventures

TRx and CTV Translational Therapeutics Seminar: Translating our understanding of T-Cell Lymphoma Pathogenesis into Novel Treatment Paradigms

May 08, 2017
Owen O'Connor, MD, PhD
Irving Institute (PH10-405)
622 W. 168th Street, 10th floor
New York, NY


The TRx pilot award is designed to provide education, mentorship, and funding to accelerate early-stage therapy discovery towards the clinic. The Translational Therapeutics Seminar Series is a 6-part series which will include speakers with varying perspectives on the drug development process, ranging from an academic investigator’s experiences to an industry investor’s perspective. 

Part two of the series features Dr. Owen O'Connor, a professor of Medicine and Experimental Therapeutics, the Director of the Center for Lymphoid Malignancies, and Co-Program Director of the Lymphoid Development and Malignancy Program at Columbia University Medical Center. 

For more information, please contact Maria Rahmany at